Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 65.82 Million USD | 31.73% |
| 2022 | 49.96 Million USD | -8.33% |
| 2021 | 54.5 Million USD | 44.55% |
| 2020 | 37.7 Million USD | 0.96% |
| 2019 | 37.34 Million USD | -32.73% |
| 2018 | 55.52 Million USD | 121.78% |
| 2017 | 25.03 Million USD | -3.93% |
| 2016 | 26.06 Million USD | 281.18% |
| 2015 | 6.83 Million USD | 11.39% |
| 2014 | 6.13 Million USD | -24.28% |
| 2013 | 8.1 Million USD | -11.65% |
| 2012 | 9.17 Million USD | -47.02% |
| 2011 | 17.31 Million USD | 8.78% |
| 2010 | 15.92 Million USD | 20.7% |
| 2009 | 13.19 Million USD | -73.2% |
| 2008 | 49.22 Million USD | 21.81% |
| 2007 | 40.4 Million USD | 231.25% |
| 2006 | 12.19 Million USD | 41.13% |
| 2005 | 8.64 Million USD | -43.42% |
| 2004 | 15.27 Million USD | 30.64% |
| 2003 | 11.69 Million USD | 61.23% |
| 2002 | 7.25 Million USD | 48.54% |
| 2001 | 4.88 Million USD | 99.63% |
| 2000 | 2.44 Million USD | 6.35% |
| 1999 | 2.3 Million USD | 43.75% |
| 1998 | 1.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 58.09 Million USD | -11.75% |
| 2024 Q3 | 59.26 Million USD | 0.7% |
| 2024 Q2 | 58.85 Million USD | 1.32% |
| 2023 Q3 | 76.48 Million USD | 20.25% |
| 2023 Q4 | 65.82 Million USD | -13.94% |
| 2023 FY | 65.82 Million USD | 31.73% |
| 2023 Q1 | 62.49 Million USD | 25.07% |
| 2023 Q2 | 63.6 Million USD | 1.78% |
| 2022 Q1 | 48.19 Million USD | -11.58% |
| 2022 Q2 | 50.92 Million USD | 5.66% |
| 2022 Q3 | 50.54 Million USD | -0.75% |
| 2022 Q4 | 49.96 Million USD | -1.13% |
| 2022 FY | 49.96 Million USD | -8.33% |
| 2021 Q1 | 30.14 Million USD | -20.05% |
| 2021 FY | 54.5 Million USD | 44.55% |
| 2021 Q2 | 35.01 Million USD | 16.14% |
| 2021 Q4 | 54.5 Million USD | 49.88% |
| 2021 Q3 | 36.36 Million USD | 3.86% |
| 2020 Q3 | 35.91 Million USD | 17.44% |
| 2020 Q2 | 30.58 Million USD | -3.63% |
| 2020 Q1 | 31.73 Million USD | -15.04% |
| 2020 FY | 37.7 Million USD | 0.96% |
| 2020 Q4 | 37.7 Million USD | 4.99% |
| 2019 Q3 | 31.7 Million USD | -11.1% |
| 2019 FY | 37.34 Million USD | -32.73% |
| 2019 Q2 | 35.66 Million USD | -3.71% |
| 2019 Q1 | 37.04 Million USD | -33.29% |
| 2019 Q4 | 37.34 Million USD | 17.79% |
| 2018 Q2 | 49.96 Million USD | 108.13% |
| 2018 Q4 | 55.52 Million USD | 8.36% |
| 2018 FY | 55.52 Million USD | 121.78% |
| 2018 Q1 | 24 Million USD | -4.11% |
| 2018 Q3 | 51.24 Million USD | 2.56% |
| 2017 Q3 | 22.54 Million USD | 3.02% |
| 2017 FY | 25.03 Million USD | -3.93% |
| 2017 Q4 | 25.03 Million USD | 11.07% |
| 2017 Q2 | 21.88 Million USD | 2.05% |
| 2017 Q1 | 21.44 Million USD | -17.72% |
| 2016 Q3 | 24.1 Million USD | 1.92% |
| 2016 FY | 26.06 Million USD | 281.18% |
| 2016 Q2 | 23.65 Million USD | 39.62% |
| 2016 Q1 | 16.94 Million USD | 147.8% |
| 2016 Q4 | 26.06 Million USD | 8.1% |
| 2015 Q1 | 5.47 Million USD | -10.82% |
| 2015 Q2 | 5.51 Million USD | 0.69% |
| 2015 Q4 | 6.83 Million USD | 9.23% |
| 2015 Q3 | 6.25 Million USD | 13.55% |
| 2015 FY | 6.83 Million USD | 11.39% |
| 2014 Q4 | 6.13 Million USD | 1.52% |
| 2014 Q1 | 6.1 Million USD | -24.65% |
| 2014 Q2 | 5.04 Million USD | -17.34% |
| 2014 Q3 | 6.04 Million USD | 19.75% |
| 2014 FY | 6.13 Million USD | -24.28% |
| 2013 Q4 | 8.1 Million USD | 37.69% |
| 2013 Q3 | 5.88 Million USD | 4.98% |
| 2013 Q1 | 9.11 Million USD | -0.66% |
| 2013 Q2 | 5.6 Million USD | -38.47% |
| 2013 FY | 8.1 Million USD | -11.65% |
| 2012 Q1 | 9.04 Million USD | -47.77% |
| 2012 FY | 9.17 Million USD | -47.02% |
| 2012 Q3 | 8.02 Million USD | -5.3% |
| 2012 Q2 | 8.47 Million USD | -6.33% |
| 2012 Q4 | 9.17 Million USD | 14.34% |
| 2011 FY | 17.31 Million USD | 8.78% |
| 2011 Q1 | 17.56 Million USD | 10.33% |
| 2011 Q2 | 18.46 Million USD | 5.13% |
| 2011 Q3 | 15.57 Million USD | -15.67% |
| 2011 Q4 | 17.31 Million USD | 11.21% |
| 2010 Q4 | 15.92 Million USD | -1.95% |
| 2010 Q3 | 16.23 Million USD | 1.91% |
| 2010 Q2 | 15.93 Million USD | 4.02% |
| 2010 Q1 | 15.31 Million USD | 16.13% |
| 2010 FY | 15.92 Million USD | 20.7% |
| 2009 Q3 | 14.18 Million USD | -28.87% |
| 2009 FY | 13.19 Million USD | -73.2% |
| 2009 Q1 | 22.73 Million USD | -53.81% |
| 2009 Q2 | 19.94 Million USD | -12.29% |
| 2009 Q4 | 13.19 Million USD | -7.01% |
| 2008 Q2 | 41.77 Million USD | 14.33% |
| 2008 FY | 49.22 Million USD | 21.81% |
| 2008 Q4 | 49.22 Million USD | -1.19% |
| 2008 Q3 | 49.81 Million USD | 19.25% |
| 2008 Q1 | 36.53 Million USD | -9.59% |
| 2007 Q2 | 8.73 Million USD | -34.86% |
| 2007 Q4 | 40.4 Million USD | 47.95% |
| 2007 Q1 | 13.4 Million USD | 9.92% |
| 2007 Q3 | 27.31 Million USD | 212.67% |
| 2007 FY | 40.4 Million USD | 231.25% |
| 2006 Q3 | 8.19 Million USD | -9.51% |
| 2006 Q4 | 12.19 Million USD | 48.86% |
| 2006 Q2 | 9.05 Million USD | 25.55% |
| 2006 Q1 | 7.21 Million USD | -16.55% |
| 2006 FY | 12.19 Million USD | 41.13% |
| 2005 Q2 | 16.09 Million USD | 55.68% |
| 2005 Q1 | 10.33 Million USD | -32.34% |
| 2005 FY | 8.64 Million USD | -43.42% |
| 2005 Q4 | 8.64 Million USD | -1.94% |
| 2005 Q3 | 8.81 Million USD | -45.22% |
| 2004 Q3 | 6.11 Million USD | -4.94% |
| 2004 FY | 15.27 Million USD | 30.64% |
| 2004 Q4 | 15.27 Million USD | 149.71% |
| 2004 Q1 | 8.96 Million USD | -23.33% |
| 2004 Q2 | 6.43 Million USD | -28.22% |
| 2003 FY | 11.69 Million USD | 61.23% |
| 2003 Q3 | 12.85 Million USD | 43.45% |
| 2003 Q2 | 8.96 Million USD | 33.43% |
| 2003 Q1 | 6.71 Million USD | -7.42% |
| 2003 Q4 | 11.69 Million USD | -9.02% |
| 2002 Q2 | 5.56 Million USD | 26.41% |
| 2002 Q1 | 4.4 Million USD | -9.89% |
| 2002 Q4 | 7.25 Million USD | 59.2% |
| 2002 Q3 | 4.55 Million USD | -18.09% |
| 2002 FY | 7.25 Million USD | 48.54% |
| 2001 Q3 | 3.58 Million USD | 32.43% |
| 2001 Q4 | 4.88 Million USD | 36.36% |
| 2001 FY | 4.88 Million USD | 99.63% |
| 2001 Q2 | 2.7 Million USD | 40.61% |
| 2001 Q1 | 1.92 Million USD | -21.38% |
| 2000 Q4 | 2.44 Million USD | 20.55% |
| 2000 Q2 | 1.82 Million USD | 21.47% |
| 2000 FY | 2.44 Million USD | 6.35% |
| 2000 Q1 | 1.5 Million USD | -34.78% |
| 2000 Q3 | 2.02 Million USD | 11.36% |
| 1999 Q4 | 2.3 Million USD | 76.92% |
| 1999 Q1 | 1.1 Million USD | -31.25% |
| 1999 Q3 | 1.3 Million USD | 18.18% |
| 1999 Q2 | 1.1 Million USD | 0.0% |
| 1999 FY | 2.3 Million USD | 43.75% |
| 1998 Q3 | 1.4 Million USD | 7.69% |
| 1998 FY | 1.6 Million USD | 0.0% |
| 1998 Q2 | 1.3 Million USD | 0.0% |
| 1998 Q4 | 1.6 Million USD | 14.29% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -28.425% |
| BrainsWay Ltd. | 15.31 Million USD | -329.822% |
| Cerus Corporation | 144.3 Million USD | 54.386% |
| Envoy Medical, Inc. | 9.4 Million USD | -600.096% |
| electroCore, Inc. | 8.94 Million USD | -635.864% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -1132.179% |
| IceCure Medical Ltd | 4.24 Million USD | -1449.87% |
| Inogen, Inc. | 121.38 Million USD | 45.772% |
| OrthoPediatrics Corp. | 72.56 Million USD | 9.286% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -122.518% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1968.642% |
| MaxCyte, Inc. | 36.1 Million USD | -82.3% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -3462.024% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -15377.531% |
| Orthofix Medical Inc. | 326.58 Million USD | 79.845% |
| PAVmed Inc | 57.13 Million USD | -15.202% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -158.504% |
| RxSight, Inc. | 22.18 Million USD | -196.66% |
| Sight Sciences, Inc. | 46.43 Million USD | -41.75% |
| SI-BONE, Inc. | 61.05 Million USD | -7.818% |
| TELA Bio, Inc. | 59.16 Million USD | -11.25% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 42.245% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -537.882% |
| Acutus Medical, Inc. | 54.83 Million USD | -20.03% |
| Talis Biomedical Corporation | 29.22 Million USD | -125.236% |
| Spectral AI, Inc. | 12.4 Million USD | -430.788% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -184.529% |
| CVRx, Inc. | 39.28 Million USD | -67.565% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -450.448% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2609.546% |
| Bioventus Inc. | 589.79 Million USD | 88.84% |
| Venus Concept Inc. | 107.1 Million USD | 38.542% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -27.408% |
| LivaNova PLC | 1.15 Billion USD | 94.286% |
| 908 Devices Inc. | 37.49 Million USD | -75.575% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 90.643% |
| Nemaura Medical Inc. | 26.37 Million USD | -149.543% |
| NeuroPace, Inc. | 86.99 Million USD | 24.339% |
| LENSAR, Inc. | 22.4 Million USD | -193.735% |
| Apyx Medical Corporation | 52.31 Million USD | -25.813% |
| Cutera, Inc. | 518.12 Million USD | 87.296% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -124.437% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1304.973% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -12.774% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -206.324% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.0% |
| Axonics, Inc. | 82.35 Million USD | 20.078% |
| Outset Medical, Inc. | 190.91 Million USD | 65.522% |
| IRIDEX Corporation | 24.91 Million USD | -164.201% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 46.902% |
| IRadimed Corporation | 20.73 Million USD | -217.434% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -3832.079% |
| INVO Bioscience, Inc. | 19.99 Million USD | -229.198% |
| Telesis Bio, Inc. | 40.87 Million USD | -61.043% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -61.37% |
| Varex Imaging Corporation | 668.6 Million USD | 90.155% |
| Quipt Home Medical Corp. | 136.29 Million USD | 51.705% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1742.749% |
| Pulmonx Corporation | 60.63 Million USD | -8.554% |
| Dynatronics Corporation | 11.78 Million USD | -458.764% |
| Modular Medical, Inc. | 2.27 Million USD | -2797.139% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1519.66% |
| Semler Scientific, Inc. | 6.27 Million USD | -949.809% |
| InMode Ltd. | 75.91 Million USD | 13.293% |
| Bruker Corporation | 2.83 Billion USD | 97.68% |
| Cytosorbents Corporation | 29.98 Million USD | -119.516% |
| DexCom, Inc. | 4.19 Billion USD | 98.431% |
| Align Technology, Inc. | 2.45 Billion USD | 97.317% |
| Viveve Medical, Inc. | 10.84 Million USD | -506.831% |
| ZimVie Inc. | 795.85 Million USD | 91.729% |
| Movano Inc. | 5.97 Million USD | -1002.194% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 37.075% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -15377.531% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -450.448% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 89.699% |
| Profound Medical Corp. | 12.66 Million USD | -419.688% |
| Insulet Corporation | 1.85 Billion USD | 96.453% |
| enVVeno Medical Corporation | 2.43 Million USD | -2603.203% |
| iCAD, Inc. | 8 Million USD | -722.685% |
| Nuwellis, Inc. | 6.78 Million USD | -870.841% |
| Biotricity, Inc. | 35.91 Million USD | -83.252% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 70.489% |
| Aethlon Medical, Inc. | 2.47 Million USD | -2554.528% |
| InspireMD, Inc. | 8.14 Million USD | -708.438% |
| PAVmed Inc. | 57.13 Million USD | -15.202% |
| BIOLASE, Inc. | 35.34 Million USD | -86.214% |
| Beyond Air, Inc. | 29.77 Million USD | -121.068% |
| FONAR Corporation | 57.45 Million USD | -14.559% |
| AxoGen, Inc. | 101.16 Million USD | 34.933% |
| Vivani Medical, Inc. | 25.03 Million USD | -162.913% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 25.027% |
| Inari Medical, Inc. | 209.32 Million USD | 68.555% |
| UFP Technologies, Inc. | 118.04 Million USD | 44.239% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -418.68% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2911.375% |
| Tenon Medical, Inc. | 5.56 Million USD | -1082.378% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -3600.0% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -273.271% |
| AdaptHealth Corp. | 3.15 Billion USD | 97.912% |
| Sintx Technologies, Inc. | 6.59 Million USD | -898.377% |
| NanoVibronix, Inc. | 2.68 Million USD | -2350.596% |
| Quanterix Corporation | 78.08 Million USD | 15.702% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1742.749% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1247.451% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 93.699% |
| TransMedics Group, Inc. | 568.84 Million USD | 88.429% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -294.575% |
| NeuroMetrix, Inc. | 1.33 Million USD | -4837.5% |
| Hyperfine, Inc. | 9.8 Million USD | -571.663% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 73.697% |
| Biomerica, Inc. | 2.66 Million USD | -2371.761% |
| Bone Biologics Corporation | 831.4 Thousand USD | -7817.109% |
| AVITA Medical, Inc. | 19.86 Million USD | -231.345% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -3235.034% |
| Silk Road Medical, Inc | 114.15 Million USD | 42.34% |